{
  "selected_clinical_test": "Hemoglobin A1c (HbA1c)",
  "justification": "HbA1c is a standardized, widely reported laboratory test for long-term glycemic control, making it highly comparable across studies. It is clinically relevant for assessing the metabolic effects of interventions in diabetes, PCOS, and cancer-related metabolic dysregulation, all of which are heavily represented in the provided data.",
  "recommended_cohorts": [
    "Type 2 Diabetes Patients on Metformin",
    "Polycystic Ovary Syndrome (PCOS) Patients on Metformin",
    "Cancer Patients on Metformin"
  ]
}